These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3896979)

  • 1. Clinical experiences with a modified BFM protocol in childhood acute lymphoblastic leukemia.
    Zintl F; Malke H; Plenert W
    Haematol Blood Transfus; 1985; 29():84-9. PubMed ID: 3896979
    [No Abstract]   [Full Text] [Related]  

  • 2. [Acute lymphoblastic leukemia in childhood: the COALL studies].
    Janka GE; Winkler K; Jürgens H; Göbel U; Gutjahr P; Spaar HJ
    Klin Padiatr; 1986; 198(3):171-7. PubMed ID: 3523023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of acute lymphoblastic leukemia in childhood and adolescence: results of the multicenter therapy study ALL-BFM 81].
    Schrappe M; Beck J; Brandeis WE; Feickert HJ; Gadner H; Graf N; Havers W; Henze G; Jobke A; Kornhuber B
    Klin Padiatr; 1987; 199(3):133-50. PubMed ID: 3306128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of acute lymphoblastic leukemia in childhood: a report for the ALL 77-02 group.
    Haas RJ; Gaedicke G; Graubner UB; Meyer G
    Haematol Blood Transfus; 1985; 29():75-7. PubMed ID: 3861493
    [No Abstract]   [Full Text] [Related]  

  • 5. [Acute lymphoblastic leukemia in infancy: results of 5 multicenter ALL-BFM therapy studies 1970-1986].
    Bucsky P; Reiter A; Ritter J; Dopfer R; Riehm H
    Klin Padiatr; 1988; 200(3):177-83. PubMed ID: 3062254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stratification by prognostic factors in the design and analysis of clinical trials for acute lymphoblastic leukemia.
    Hammond GD; Sather H; Bleyer WA; Coccia P
    Haematol Blood Transfus; 1987; 30():161-6. PubMed ID: 3305192
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of acute lymphoblastic leukemia in children with the BFM protocol: a cooperative study and analysis of prognostic factors.
    Maurus R; Boilletot A; Otten J; Philippe N; Benoit Y; Behar C; Casteels-Van Daele M; Chantraine JM; Delbeke MJ; Gyselinck J
    Haematol Blood Transfus; 1987; 30():466-70. PubMed ID: 3305214
    [No Abstract]   [Full Text] [Related]  

  • 8. Risk groups in adult acute lymphoblastic leukemia.
    Hoelzer D; Thiel E; Löffler H; Ganser A; Heimpel H; Büchner T; Urbanitz D; Koch P; Freund M; Diedrich H
    Haematol Blood Transfus; 1987; 30():104-10. PubMed ID: 3305188
    [No Abstract]   [Full Text] [Related]  

  • 9. Prognostic factors and therapy in acute lymphoblastic leukemia of childhood: CCG-141. A report from childrens cancer study group.
    Miller DR; Leikin S; Albo V; Sather H; Karon M; Hammond D
    Cancer; 1983 Mar; 51(6):1041-9. PubMed ID: 6336986
    [No Abstract]   [Full Text] [Related]  

  • 10. [Corticosteroid-dependent reduction of leukocyte count in blood as a prognostic factor in acute lymphoblastic leukemia in childhood (therapy study ALL-BFM 83)].
    Riehm H; Reiter A; Schrappe M; Berthold F; Dopfer R; Gerein V; Ludwig R; Ritter J; Stollmann B; Henze G
    Klin Padiatr; 1987; 199(3):151-60. PubMed ID: 3306129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute lymphoblastic leukemia: current status of therapy in children.
    Lampert F; Henze G; Langermann HJ; Schellong G; Gadner H; Riehm HJ
    Recent Results Cancer Res; 1984; 93():159-81. PubMed ID: 6382478
    [No Abstract]   [Full Text] [Related]  

  • 12. [Evaluation of two methods of maintenance chemotherapy with methotrexate and 6-mercaptopurine for childhood acute lymphoblastic leukemia].
    Kawai S; Fujimoto T; Hiyoshi Y; Nibu K; Ito M; Kadoya S; Shingaki Y
    Rinsho Ketsueki; 1984 Jun; 25(6):819-26. PubMed ID: 6384569
    [No Abstract]   [Full Text] [Related]  

  • 13. Strategies for the treatment of children with acute lymphoblastic leukemia and unfavorable presenting features.
    Gaynon PS; Steinherz PG; Reaman GH; Bleyer WA; Sather H; Hammond GD
    Haematol Blood Transfus; 1987; 30():167-72. PubMed ID: 3305193
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapeutic study VII/81 of the treatment of acute lymphoblastic leukemia in childhood].
    Zintl F; Plenert W; Malke H; Blau HJ; Dörffel W; Exadaktylos P; Hofmann K; Korth G; Kotte W; Kuhnert W
    Kinderarztl Prax; 1986 Mar; 54(3):141-52. PubMed ID: 3520095
    [No Abstract]   [Full Text] [Related]  

  • 15. [Incidence, clinical markers and prognostic significance of immunologic subtypes of acute lymphoblastic leukemia (ALL) in children: experiences of the ALL-BFM 83 and 86 studies].
    Ludwig WD; Teichmann JV; Sperling C; Komischke B; Ritter J; Reiter A; Odenwald E; Sauter S; Riehm H
    Klin Padiatr; 1990; 202(4):243-52. PubMed ID: 2203938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The fate of children after discontinuation of treatment of lymphoblastic leukemia in the light of experiences of the Polish Group for the Treatment of Leukemia and Other Neoplastic Diseases of the Hematopoietic System in Children].
    Derulska D; Rokicka-Milewska R; Ochocka M; Newecka T
    Acta Haematol Pol; 1985; 16(1-2):7-13. PubMed ID: 3868909
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term follow-up after therapy cessation in childhood acute lymphoblastic leukemia.
    Rokicka-Milewska R; Derulska D; Armata J; Balwierz W; Bogusławska-Jaworska J; Cyklis R; Duczmal B; Michalewska D; Newecka T; Ochocka M
    Haematol Blood Transfus; 1987; 31():37-8. PubMed ID: 3327777
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment strategy for different risk groups in childhood acute lymphoblastic leukemia: A Report From the BFM Study Group.
    Henze G; Langermann HJ; Ritter J; Schellong G; Riehm H
    Haematol Blood Transfus; 1981; 26():87-93. PubMed ID: 6947941
    [No Abstract]   [Full Text] [Related]  

  • 19. [Intensification of treatment of lymphoblastic leukemia in children].
    Michalewska D; Radwańska U
    Pediatr Pol; 1985 Jan; 60(1):5-13. PubMed ID: 3862059
    [No Abstract]   [Full Text] [Related]  

  • 20. [Concept and interim result of the ALL-BFM 90 therapy study in treatment of acute lymphoblastic leukemia in children and adolescents: the significance of initial therapy response in blood and bone marrow].
    Schrappe M; Reiter A; Sauter S; Ludwig WD; Wörmann B; Harbott J; Bender-Götze C; Dörffel W; Dopfer R; Frey E
    Klin Padiatr; 1994; 206(4):208-21. PubMed ID: 7526027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.